News

Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
The Hearty Soul on MSN8h
Father Shares Experience of Illness Following Pfizer COVID Vaccine, Discusses Recovery
According to Pfizer, "Hundreds of millions of doses of the Pfizer-BioNTech COVID-19 vaccine have been administered globally, ...
The Observer on MSN7h
I founded Teach First – I know how much it has helped children
Disadvantaged communities need society’s absolute best leaders in their schools. This charity ensures they get them ...
Barclays Keeps Their Buy Rating on Tapestry (TPR)
In a report released today, Adrienne Yih from Barclays maintained a Buy rating on Tapestry, with a price target of $105.00. The company’s shares closed yesterday at $97.64. Elev ...